Reactive oxygen species-mediated mitochondrial apoptosis pathway (ROS/Mitochondrial Apoptosis Pathway)

The Reactive Oxygen Species (ROS) pathway and mitochondrial apoptosis machinery constitute a fundamental regulatory network that determines cell fate in response to physiological and pathological stress (Redza-Dutordoir & Averill-Bates, 2016, PMID: 26845323). ROS are primarily generated within the mitochondria during oxidative phosphorylation and serve as critical secondary messengers in signal transduction; however, when levels exceed the cell's antioxidant capacity, they trigger the intrinsic apoptotic pathway by promoting Mitochondrial Outer Membrane Permeabilization (MOMP) (Sinha et al., 2013, PMID: 23748124). This machinery is tightly controlled by the Bcl-2 family of proteins, which balance pro-apoptotic signals (e.g., Bax, Bak) and anti-apoptotic signals (e.g., Bcl-2, Bcl-xL) (Galluzzi et al., 2018, PMID: 29362479). The subsequent release of mitochondrial intermembrane space proteins, such as Cytochrome c, into the cytoplasm leads to the formation of the apoptosome and activation of the executioner caspase cascade. In oncology, many chemotherapeutic agents and targeted therapies, such as BH3 mimetics like Venetoclax, aim to exploit or restore this machinery to eliminate resistant tumor cells (Adams & Cory, 2007, PMID: 17548527). Conversely, in neurodegenerative and cardiovascular diseases, therapeutic strategies often focus on inhibiting this pathway to prevent the premature loss of post-mitotic cells due to oxidative damage.

Other names

Intrinsic apoptotic pathwayMitochondrial death pathwayROS-induced apoptosisMitochondrial outer membrane permeabilization (MOMP) pathwayBcl-2 regulated apoptotic pathway

Drugs modulate this machinery by either inhibiting anti-apoptotic Bcl-2 family proteins (BH3 mimetics) to lower the apoptotic threshold, inducing lethal levels of ROS to trigger MOMP in malignant cells, or utilizing antioxidants to scavenge ROS and prevent mitochondrial-mediated cell death in degenerative conditions.